(Q45190964)

10 December 2017

title

The use of semi-automated EBV IgG avidity determination for the diagnosis of infectious mononucleosis (English)

1 reference

10 December 2017

Weissbrich B

1

1 reference

10 December 2017

publication date

1 February 1998

1 reference

Journal of Medical Virology

10 December 2017

published in

1 reference

10 December 2017

volume

54

1 reference

10 December 2017

issue

2

1 reference

10 December 2017

page(s)

145-153

1 reference

Avidities of IgG directed against viral capsid antigen or early antigen: useful markers for significant Epstein-Barr virus serology

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

A Prospective Evaluation of Heterophile and Epstein-Barr Virus-Specific IgM Antibody Tests in Clinical and Subclinical Infectious Mononucleosis: Specificity and Sensitivity of the Tests and Persistence of Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Primary Infection with Epstein-Barr Virus in Infants in the United States: Clinical and Serologic Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Rapid diagnosis of hantavirus disease with an IgG-avidity assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Epstein-Barr virus specific diagnostic tests in infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Antibody avidity following varicella-zoster virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Stepwise intraclonal maturation of antibody affinity through somatic hypermutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Study Of Epstein Barr Virus (Eby) Antibodies: IgG AND lgM Anti -VCA, lgG Anti-Ea and lgAnti-Ebna Obtained with an Original Microtiter Technique: Serological Criterions of Primary and Recurrent Eby Infections and Follow-Up of Infectious Mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Longitudinal study of epstein-barr virus antibody titers and excretion in pediatric patients with Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

IgM antibodies specific for Epstein-Barr virus in infectious mononucleosis without heterophil antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Epstein-Barr virus and human diseases: recent advances in diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Acute Epstein-Barr virus infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Endogenous Reactivation of Epstein-Barr Virus Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Differentiation of primary from secondary anti-EBNA-1-negative cases by determination of avidity of VCA-IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Avidity of IgG antibodies to human herpesvirus-6 distinguishes primary from recurrent infection in organ transplant recipients and excludes cross-reactivity with other herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Evaluation of 11 enzyme immunoassays for the detection of immunoglobulin M antibodies to Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Avidity of EBV VCA-specific IgG antibodies: distinction between recent primary infection, past infection and reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Recent primary toxoplasma infection indicated by a low avidity of specific IgG

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Measurement of avidity of specific IgG for verification of recent primary rubella

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

Detection of acute measles infections by indirect and mu-capture enzyme immunoassays for immunoglobulin M antibodies and measles immunoglobulin G antibody avidity enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C145%3A%3AAID-JMV13%3E3.0.CO%3B2-I

10.1002/(SICI)1096-9071(199802)54:2<145::AID-JMV13>3.0.CO;2-I

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference